IRIS
TESSITORE, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.909
EU - Europa 2.286
AS - Asia 1.388
SA - Sud America 213
AF - Africa 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.891
IE - Irlanda 557
CN - Cina 454
SG - Singapore 416
IT - Italia 361
SE - Svezia 285
DE - Germania 278
TR - Turchia 246
RU - Federazione Russa 212
BR - Brasile 193
HK - Hong Kong 190
UA - Ucraina 142
GB - Regno Unito 136
FR - Francia 123
FI - Finlandia 100
CZ - Repubblica Ceca 39
VN - Vietnam 30
BE - Belgio 23
IN - India 16
CA - Canada 12
BD - Bangladesh 6
NL - Olanda 6
KR - Corea 5
AR - Argentina 4
AU - Australia 4
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
VE - Venezuela 4
AT - Austria 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
MX - Messico 3
PY - Paraguay 3
TN - Tunisia 3
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 6.812
Salva come PNG Salva come JPEG
Città #
Chandler 622
Jacksonville 565
Dublin 553
Boardman 227
Singapore 220
Santa Clara 195
Hong Kong 189
Izmir 134
Nanjing 98
Princeton 80
San Mateo 80
Lawrence 79
New York 74
Wilmington 74
Ann Arbor 73
Beijing 58
L'aquila 55
Moscow 55
L’Aquila 49
Munich 47
Bremen 45
Woodbridge 43
Brno 39
Helsinki 38
Ashburn 36
Nanchang 35
Milan 34
Shenyang 29
Dong Ket 28
Los Angeles 27
Rome 26
Seattle 25
Brussels 23
Shanghai 23
Tianjin 22
Verona 22
Aquila 20
Kitzingen 20
Council Bluffs 19
Dallas 15
Des Moines 15
Jiaxing 15
Mountain View 15
Casoria 14
Hebei 14
Kunming 13
São Paulo 13
The Dalles 13
Zhengzhou 13
Changsha 12
Philadelphia 12
Falkenstein 10
Norwalk 10
Dearborn 9
Guangzhou 9
Ningbo 9
Pune 9
Jinan 8
Redwood City 8
Houston 7
Lissone 7
Taizhou 7
Auburn Hills 6
Bari 6
Berlin 6
Toronto 6
Bellante 5
Fremont 5
Menlo Park 5
Campinas 4
Carapicuíba 4
Caserta 4
Changchun 4
Edinburgh 4
Frankfurt am Main 4
Hangzhou 4
Joinville 4
London 4
Porto Alegre 4
Absecon 3
Belo Horizonte 3
Brasília 3
Chicago 3
Clifton 3
Falls Church 3
Fortaleza 3
Haikou 3
Hefei 3
João Pessoa 3
Lanzhou 3
Nuremberg 3
Ottawa 3
Pittsburgh 3
Pollenza 3
Redmond 3
Santiago 3
Turin 3
Acerra 2
Alta Floresta 2
Amman 2
Totale 4.477
Salva come PNG Salva come JPEG
Nome #
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 148
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 141
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 131
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 129
Therapeutic Use of MicroRNAs in Cancer 120
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 119
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 119
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 116
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 114
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 114
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 113
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 113
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 108
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 106
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 105
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 104
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 103
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 100
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 99
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 93
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 92
crosstalk between nf-kb and shh pathways in prostate cancer 91
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 90
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 87
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 87
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 86
the role of kctd11 tumor suppressor gene in prostate cancer 86
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 84
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 84
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 83
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 83
New mutations and protein variants of NBSI are identified in cancer cell lines 82
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 81
Novel P53 mutations detected by FAMA in colorectal cancers 80
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 79
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 79
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 78
Emerging role of isomirs in cancer: State of the art and recent advances 78
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 77
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 76
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 75
MicroRNAs in the DNA Damage/Repair Network and Cancer 75
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 75
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 74
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 74
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 73
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 73
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 73
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 71
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 71
Prognostic value of p53 molecular status in high-risk primary breast cancer 71
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 71
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 70
Serum low-molecular-weight protein fractionation for biomarker discovery 70
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 70
Identification of a novel HLA-A*02 allele, A*027401* 69
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 68
Role of bcr-abl in the regulation and inhibition of apoptosis 67
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 67
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 67
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 67
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 67
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 66
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 65
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 65
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 65
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 65
Codon optimization by 0-1 linear programming 65
An initial characterization of the serum phosphoproteome. 63
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 62
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 61
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 61
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 59
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 57
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 57
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 55
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 55
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 54
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 52
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 50
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 44
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 43
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 42
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 39
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 38
null 38
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 36
null 35
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 32
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 28
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 26
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 24
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 21
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 17
Totale 7.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 0 0 0 0 0 0 5 77
2020/2021756 26 75 6 75 89 36 99 39 83 39 129 60
2021/2022514 35 25 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/20251.733 83 62 228 103 193 158 278 188 366 68 6 0
Totale 7.056